These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 11961505)

  • 21. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.
    Kobayashi H; Dorai T; Holland JF; Ohnuma T
    Cancer Res; 1994 Mar; 54(5):1271-5. PubMed ID: 8118816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cleavage of the Ewing tumour-specific EWSR1-FLI1 mRNA by hammerhead ribozymes.
    Hühn R; Staege MS; Hesse M; Liebig B; Burdach SE
    Anticancer Res; 2009 Jun; 29(6):1901-8. PubMed ID: 19528446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ribozyme gene therapy for autosomal dominant retinal disease.
    Hauswirth WW; LaVail MM; Flannery JG; Lewin AS
    Clin Chem Lab Med; 2000 Feb; 38(2):147-53. PubMed ID: 10834402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
    Cai DW; Mukhopadhyay T; Roth JA
    Cancer Gene Ther; 1995 Sep; 2(3):199-205. PubMed ID: 8528963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential activity of trans-acting hammerhead ribozymes targeted to beta amyloid peptide precursor mRNA by altering the symmetry of helices I and III.
    Denman RB; Smedman M; Kung L
    Arch Biochem Biophys; 1995 Oct; 323(1):71-8. PubMed ID: 7487076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preparation and characterization of ribozyme for tissue inhibitor of metalloproteinases-1 mRNA ribozymes in vitro].
    Wang ZM; Wu JM; Lin ZH; Jiang H; Song YH; Jin YX
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):387-90. PubMed ID: 12673396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ribozyme-mediated cleavage of the human survivin mRNA and inhibition of antiapoptotic function of survivin in MCF-7 cells.
    Choi KS; Lee TH; Jung MH
    Cancer Gene Ther; 2003 Feb; 10(2):87-95. PubMed ID: 12536196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of photoreceptor morphology and function in P23H rats using an allele independent ribozyme.
    Gorbatyuk M; Justilien V; Liu J; Hauswirth WW; Lewin AS
    Exp Eye Res; 2007 Jan; 84(1):44-52. PubMed ID: 17083931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A ribozyme targeted to RNA polymerase gene of infectious bursal disease virus effectively cleaves and inhibits expression of the viral gene product.
    Akin A; Lin TL; Wu CC
    Acta Virol; 1999 Dec; 43(6):341-7. PubMed ID: 10825922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-ribozyme targeting of human alpha-globin gene expression.
    Shen TJ; Ikonomi P; Smith R; Noguchi CT; Ho C
    Blood Cells Mol Dis; 1999; 25(5-6):361-73. PubMed ID: 10660485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy.
    Mendes HF; van der Spuy J; Chapple JP; Cheetham ME
    Trends Mol Med; 2005 Apr; 11(4):177-85. PubMed ID: 15823756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial virus phi29 pRNA as a hammerhead ribozyme escort to destroy hepatitis B virus.
    Hoeprich S; Zhou Q; Guo S; Shu D; Qi G; Wang Y; Guo P
    Gene Ther; 2003 Aug; 10(15):1258-67. PubMed ID: 12858191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.
    Yokoyama Y; Takahashi Y; Shinohara A; Lian Z; Wan X; Niwa K; Tamaya T
    Cancer Res; 1998 Dec; 58(23):5406-10. PubMed ID: 9850072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel Xenopus SWS2, P434 visual pigment: structure, cellular location, and spectral analyses.
    Darden AG; Wu BX; Znoiko SL; Hazard ES; Kono M; Crouch RK; Ma JX
    Mol Vis; 2003 May; 9():191-9. PubMed ID: 12764253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation of hammerhead ribozymes with altered core sequences by in vitro selection.
    Vaish NK; Heaton PA; Eckstein F
    Biochemistry; 1997 May; 36(21):6495-501. PubMed ID: 9174367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 221-bp fragment of the mouse opsin promoter directs expression specifically to the rod photoreceptors of transgenic mice.
    Quiambao AB; Peachey NS; Mangini NJ; Röhlich P; Hollyfield JG; al-Ubaidi MR
    Vis Neurosci; 1997; 14(4):617-25. PubMed ID: 9278991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity identification of anti-caspase-3 mRNA hammerhead ribozyme in both cell-free condition and BRL-3A cells.
    Xu R; Liu J; Zhou X; Xie Q; Jin Y; Yu H; Liao D
    Chin Med J (Engl); 2001 Jun; 114(6):606-11. PubMed ID: 11780436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
    Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M
    Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-cleaving-ribozyme-mediated reduction of betaAPP in human rhabdomyosarcoma cells.
    Dolzhanskaya N; Conti J; Schwenk V; Merz G; Denman RB
    Arch Biochem Biophys; 2001 Mar; 387(2):223-32. PubMed ID: 11370845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.